Abstract Objectives To test the hypothesis that prenatal administration of PPARα agonist clofibrate may increase the developmental beige adipocytes and permanently increased the browning capacity of white adipose tissue (WAT). Methods Pregnant C57BL/6 J mice received a basal diet, without (C) or with 0.5% clofibrate (CF, a PPARα agonist) throughout pregnancy. After parturition, only male offspring were used; all suckled their mothers (who were eating the C diet) and after weaning, they ate a standard chow diet for 4 wk, followed by a high-fat diet (HFD) for 5 wk. Results CF administration significantly increased the expression of PPARα and its target genes. CF elevated serum concentrations and hepatic expression of FGF21 (a thermogenic hormone) in fetuses, with a return to basal levels after CF withdrawal. At postnatal day 84 (P84), CF-offspring had significantly higher mRNA and protein levels of UCP1 in response to HFD in inguinal (iWAT) but not in visceral fats. Based on UCP1 levels in iWAT on P7, P14, and P21, the appearance of the transient brown-adipocyte phenotype seemed to be hastened by prenatal CF exposure. The mRNA level of UCP1 is peaked at P14 in CF-offspring, unlike C-offspring which peaked at P21. However, the mRNA level of beige cell markers (Cd137, Tmem26, Tbx1) maintained the same across this time window (P7–21). Microarray analysis of global gene expression in iWAT during this time window is conducting, as well as serum level of leptin, since leptin surge is essential to the formation of beige adipocytes during this time window. Conclusions Giving CF to pregnant mice programmed greater HFD-induced WAT browning in subcutaneous, but not in visceral fat, in their male offspring at adulthood. We foresee the transient browning of iWAT occurred at critical window may offer clues for elucidating this interesting phenomenon. Funding Sources Ministry of Science and Technology, Taiwan.